サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1356800

イメージングバイオマーカー市場レポート：2030年までの動向、予測、競合分析

Imaging Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

イメージングバイオマーカー市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

イメージングバイオマーカーの動向と予測

世界のイメージングバイオマーカー市場は、2024年から2030年までのCAGRが14.6%で、2030年までに推定177億米ドルに達すると予測されています。この市場の主な促進要因は、慢性症例の増加、イメージングバイオマーカーの仮想化やビッグデータ技術などの技術的躍進、世界のヘルスケア志向の高まりなどです。世界のイメージングバイオマーカー市場の将来は、個別化医療、創薬・薬剤開拓、分子診断、薬剤製剤、疾病診断、法医学市場における機会で有望視されています。

イメージングバイオマーカー市場の洞察

Lucintelは、磁気共鳴画像は脊髄病変、がん、血管障害、脳障害の検出に役立つため、予測期間中も最大セグメントであり続けると予測しています。

疾患診断は、新薬が意図されたターゲットに到達する患者集団の特徴付けを可能にする能力により、最大セグメントであり続けると思われます。

北米は、病気に対する意識の高まりと技術的進歩の成長により、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のイメージングバイオマーカー市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のイメージングバイオマーカー市場動向（2018-2023）および予測（2024-2030）
  • 技術別の世界のイメージングバイオマーカー市場
    • 陽電子放出断層撮影
    • 超音波
    • 磁気共鳴画像
    • コンピュータ断層撮影
    • 単一光子放射コンピュータ断層撮影法
    • その他
  • アプリケーション別の世界のイメージングバイオマーカー市場
    • 個別化医療
    • 創薬と開発
    • 分子診断学
    • 医薬品の製剤化
    • 病気の診断
    • フォレンジックアプリケーション
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のイメージングバイオマーカー市場
  • 北米の画像バイオマーカー市場
  • 欧州の画像バイオマーカー市場
  • アジア太平洋イメージングバイオマーカー市場
  • その他地域イメージングバイオマーカー市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 技術別の世界のイメージングバイオマーカー市場の成長機会
    • アプリケーション別の世界のイメージングバイオマーカー市場の成長機会
    • 地域別の世界のイメージングバイオマーカー市場の成長機会
  • 世界のイメージングバイオマーカー市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のイメージングバイオマーカー市場の能力拡大
    • 世界のイメージングバイオマーカー市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Siemens Healthineers
  • ICON
  • Invicro
  • Median Technologies
  • PI Solutions
  • IXICO
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • BRAINOMIX
目次

Imaging Biomarker Trends and Forecast

The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets. The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.

A more than 150-page report is developed to help in your business decisions.

Imaging Biomarker by Segment

The study includes a forecast for the global imaging biomarker by technology, application, and region.

Imaging Biomarker Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Positron Emission Tomography
  • Ultrasound
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Single-Photon Emission Computed Tomography
  • Others

Imaging Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Personalized Medicines
  • Drug Discovery and Development
  • Molecular Diagnostics
  • Drug Formulation
  • Disease Diagnosis
  • Forensic Applications
  • Others

Imaging Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Imaging Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies imaging biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the imaging biomarker companies profiled in this report include-

  • Siemens Healthineers
  • Icon
  • Invicro
  • Median Technologies
  • Pi Solutions
  • Ixico
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • Brainomix

Imaging Biomarker Market Insights

Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.

Disease diagnosis will remain the largest segment due to their ability to enable the characterization of patient populations to which new drugs reach intended targets.

North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.

Features of the Global Imaging Biomarker Market

Market Size Estimates: Imaging biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Imaging biomarker market size by technology, application, and region. in terms of value ($B).

Regional Analysis: Imaging biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, and region.s for the imaging biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the imaging biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the imaging biomarker market size?

Answer: The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030.

Q.2. What is the growth forecast for imaging biomarker market?

Answer: The global imaging biomarker market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the imaging biomarker market?

Answer: The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.

Q.4. What are the major segments for imaging biomarker market?

Answer: The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets.

Q.5. Who are the key imaging biomarker market companies?

Answer: Some of the key imaging biomarker companies are as follows:

  • Siemens Healthineers
  • ICON
  • Invicro
  • Median Technologies
  • PI Solutions
  • IXICO
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • BRAINOMIX

Q.6. Which imaging biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.

Q.7. In imaging biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the imaging biomarker market by technology (positron emission tomography, ultrasound, magnetic resonance imaging,computed tomography, single-photon emission computed tomography, and others) application (personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis, forensic applications, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Imaging Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Imaging Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Imaging Biomarker Market by Technology
    • 3.3.1: Positron Emission Tomography
    • 3.3.2: Ultrasound
    • 3.3.3: Magnetic Resonance Imaging
    • 3.3.4: Computed Tomography
    • 3.3.5: Single-Photon Emission Computed Tomography
    • 3.3.6: Others
  • 3.4: Global Imaging Biomarker Market by Application
    • 3.4.1: Personalized Medicines
    • 3.4.2: Drug Discovery and Development
    • 3.4.3: Molecular Diagnostics
    • 3.4.4: Drug Formulation
    • 3.4.5: Disease Diagnosis
    • 3.4.6: Forensic Applications
    • 3.4.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Imaging Biomarker Market by Region
  • 4.2: North American Imaging Biomarker Market
    • 4.2.2: North American Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.3: European Imaging Biomarker Market
    • 4.3.1: European Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.3.2: European Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.4: APAC Imaging Biomarker Market
    • 4.4.1: APAC Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.4.2: APAC Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.5: ROW Imaging Biomarker Market
    • 4.5.1: ROW Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.5.2: ROW Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Othersers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Imaging Biomarker Market by Technology
    • 6.1.2: Growth Opportunities for the Global Imaging Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Imaging Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Imaging Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Imaging Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Imaging Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthineers
  • 7.2: ICON
  • 7.3: Invicro
  • 7.4: Median Technologies
  • 7.5: PI Solutions
  • 7.6: IXICO
  • 7.7: Bioxydyn
  • 7.8: Zionexa
  • 7.9: Imabiotech
  • 7.10: BRAINOMIX